 | • レポートコード：QYR2104Z2952 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ヒトマイクロバイオームのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消化管ヒトマイクロバイオーム、泌尿生殖器ヒトマイクロバイオーム、その他）、用途別市場規模（治療、診断）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ヒトマイクロバイオームの市場動向 ・企業の競争状況、市場シェア ・ヒトマイクロバイオームの種類別市場規模（消化管ヒトマイクロバイオーム、泌尿生殖器ヒトマイクロバイオーム、その他） ・ヒトマイクロバイオームの用途別市場規模（治療、診断） ・ヒトマイクロバイオームの北米市場規模2016-2027（アメリカ、カナダ） ・ヒトマイクロバイオームのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒトマイクロバイオームのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒトマイクロバイオームの中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒトマイクロバイオームの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Vedanta、Seres Therapeutics、Second Genome、Rebiotix、ActoGeniX、Enterome BioScience、AvidBiotics、4D Pharma Research Ltd、Enterologics、Metabogen、Metabiomics、Ritter Pharmaceuticals、Osel、Symberix、Miomics、Symbiotix Biotherapies、MicroBiome Therapeutics LLC） ・結論 |
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that’s 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The research usually can last 8-10 years, so scale production will occur in 2018. Before then, the Human Micobiome companies have to continue deficit.
Market Analysis and Insights: Global Human Microbiome Market
The global Human Microbiome market size is projected to reach US$ 1027.5 million by 2026, from US$ 256.2 million in 2019, at a CAGR of 21.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Microbiome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Microbiome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Microbiome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Microbiome market.
Global Human Microbiome Scope and Market Size
Human Microbiome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Microbiome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Segment by Application
Treatment
Diagnosis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Rebiotix
ActoGeniX
Ritter Pharmaceuticals
Osel
Symberix
Miomics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gastrointestinal Tract Human Micobiome
1.2.3 Urogenital Tract Human Micobiome
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Microbiome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Market Perspective (2016-2027)
2.2 Human Microbiome Growth Trends by Regions
2.2.1 Human Microbiome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Microbiome Historic Market Share by Regions (2016-2021)
2.2.3 Human Microbiome Forecasted Market Size by Regions (2022-2027)
2.3 Human Microbiome Industry Dynamic
2.3.1 Human Microbiome Market Trends
2.3.2 Human Microbiome Market Drivers
2.3.3 Human Microbiome Market Challenges
2.3.4 Human Microbiome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Players by Revenue
3.1.1 Global Top Human Microbiome Players by Revenue (2016-2021)
3.1.2 Global Human Microbiome Revenue Market Share by Players (2016-2021)
3.2 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Revenue
3.4 Global Human Microbiome Market Concentration Ratio
3.4.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2020
3.5 Human Microbiome Key Players Head office and Area Served
3.6 Key Players Human Microbiome Product Solution and Service
3.7 Date of Enter into Human Microbiome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Breakdown Data by Type
4.1 Global Human Microbiome Historic Market Size by Type (2016-2021)
4.2 Global Human Microbiome Forecasted Market Size by Type (2022-2027)
5 Human Microbiome Breakdown Data by Application
5.1 Global Human Microbiome Historic Market Size by Application (2016-2021)
5.2 Global Human Microbiome Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Human Microbiome Market Size (2016-2027)
6.2 North America Human Microbiome Market Size by Type
6.2.1 North America Human Microbiome Market Size by Type (2016-2021)
6.2.2 North America Human Microbiome Market Size by Type (2022-2027)
6.2.3 North America Human Microbiome Market Size by Type (2016-2027)
6.3 North America Human Microbiome Market Size by Application
6.3.1 North America Human Microbiome Market Size by Application (2016-2021)
6.3.2 North America Human Microbiome Market Size by Application (2022-2027)
6.3.3 North America Human Microbiome Market Size by Application (2016-2027)
6.4 North America Human Microbiome Market Size by Country
6.4.1 North America Human Microbiome Market Size by Country (2016-2021)
6.4.2 North America Human Microbiome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Human Microbiome Market Size (2016-2027)
7.2 Europe Human Microbiome Market Size by Type
7.2.1 Europe Human Microbiome Market Size by Type (2016-2021)
7.2.2 Europe Human Microbiome Market Size by Type (2022-2027)
7.2.3 Europe Human Microbiome Market Size by Type (2016-2027)
7.3 Europe Human Microbiome Market Size by Application
7.3.1 Europe Human Microbiome Market Size by Application (2016-2021)
7.3.2 Europe Human Microbiome Market Size by Application (2022-2027)
7.3.3 Europe Human Microbiome Market Size by Application (2016-2027)
7.4 Europe Human Microbiome Market Size by Country
7.4.1 Europe Human Microbiome Market Size by Country (2016-2021)
7.4.2 Europe Human Microbiome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Market Size (2016-2027)
8.2 Asia-Pacific Human Microbiome Market Size by Type
8.2.1 Asia-Pacific Human Microbiome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Microbiome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Microbiome Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Microbiome Market Size by Application
8.3.1 Asia-Pacific Human Microbiome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Microbiome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Microbiome Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Microbiome Market Size by Region
8.4.1 Asia-Pacific Human Microbiome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Microbiome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human Microbiome Market Size (2016-2027)
9.2 Latin America Human Microbiome Market Size by Type
9.2.1 Latin America Human Microbiome Market Size by Type (2016-2021)
9.2.2 Latin America Human Microbiome Market Size by Type (2022-2027)
9.2.3 Latin America Human Microbiome Market Size by Type (2016-2027)
9.3 Latin America Human Microbiome Market Size by Application
9.3.1 Latin America Human Microbiome Market Size by Application (2016-2021)
9.3.2 Latin America Human Microbiome Market Size by Application (2022-2027)
9.3.3 Latin America Human Microbiome Market Size by Application (2016-2027)
9.4 Latin America Human Microbiome Market Size by Country
9.4.1 Latin America Human Microbiome Market Size by Country (2016-2021)
9.4.2 Latin America Human Microbiome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Market Size (2016-2027)
10.2 Middle East & Africa Human Microbiome Market Size by Type
10.2.1 Middle East & Africa Human Microbiome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Microbiome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Microbiome Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Microbiome Market Size by Application
10.3.1 Middle East & Africa Human Microbiome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Microbiome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Microbiome Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Microbiome Market Size by Country
10.4.1 Middle East & Africa Human Microbiome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Microbiome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Vedanta
11.1.1 Vedanta Company Details
11.1.2 Vedanta Business Overview
11.1.3 Vedanta Human Microbiome Introduction
11.1.4 Vedanta Revenue in Human Microbiome Business (2016-2021)
11.1.5 Vedanta Recent Development
11.2 Seres Therapeutics
11.2.1 Seres Therapeutics Company Details
11.2.2 Seres Therapeutics Business Overview
11.2.3 Seres Therapeutics Human Microbiome Introduction
11.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2016-2021)
11.2.5 Seres Therapeutics Recent Development
11.3 Second Genome
11.3.1 Second Genome Company Details
11.3.2 Second Genome Business Overview
11.3.3 Second Genome Human Microbiome Introduction
11.3.4 Second Genome Revenue in Human Microbiome Business (2016-2021)
11.3.5 Second Genome Recent Development
11.4 Rebiotix
11.4.1 Rebiotix Company Details
11.4.2 Rebiotix Business Overview
11.4.3 Rebiotix Human Microbiome Introduction
11.4.4 Rebiotix Revenue in Human Microbiome Business (2016-2021)
11.4.5 Rebiotix Recent Development
11.5 ActoGeniX
11.5.1 ActoGeniX Company Details
11.5.2 ActoGeniX Business Overview
11.5.3 ActoGeniX Human Microbiome Introduction
11.5.4 ActoGeniX Revenue in Human Microbiome Business (2016-2021)
11.5.5 ActoGeniX Recent Development
11.6 Enterome BioScience
11.6.1 Enterome BioScience Company Details
11.6.2 Enterome BioScience Business Overview
11.6.3 Enterome BioScience Human Microbiome Introduction
11.6.4 Enterome BioScience Revenue in Human Microbiome Business (2016-2021)
11.6.5 Enterome BioScience Recent Development
11.7 AvidBiotics
11.7.1 AvidBiotics Company Details
11.7.2 AvidBiotics Business Overview
11.7.3 AvidBiotics Human Microbiome Introduction
11.7.4 AvidBiotics Revenue in Human Microbiome Business (2016-2021)
11.7.5 AvidBiotics Recent Development
11.8 4D Pharma Research Ltd
11.8.1 4D Pharma Research Ltd Company Details
11.8.2 4D Pharma Research Ltd Business Overview
11.8.3 4D Pharma Research Ltd Human Microbiome Introduction
11.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2016-2021)
11.8.5 4D Pharma Research Ltd Recent Development
11.9 Enterologics
11.9.1 Enterologics Company Details
11.9.2 Enterologics Business Overview
11.9.3 Enterologics Human Microbiome Introduction
11.9.4 Enterologics Revenue in Human Microbiome Business (2016-2021)
11.9.5 Enterologics Recent Development
11.10 Metabogen
11.10.1 Metabogen Company Details
11.10.2 Metabogen Business Overview
11.10.3 Metabogen Human Microbiome Introduction
11.10.4 Metabogen Revenue in Human Microbiome Business (2016-2021)
11.10.5 Metabogen Recent Development
11.11 Metabiomics
11.11.1 Metabiomics Company Details
11.11.2 Metabiomics Business Overview
11.11.3 Metabiomics Human Microbiome Introduction
11.11.4 Metabiomics Revenue in Human Microbiome Business (2016-2021)
11.11.5 Metabiomics Recent Development
11.12 Ritter Pharmaceuticals
11.12.1 Ritter Pharmaceuticals Company Details
11.12.2 Ritter Pharmaceuticals Business Overview
11.12.3 Ritter Pharmaceuticals Human Microbiome Introduction
11.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2016-2021)
11.12.5 Ritter Pharmaceuticals Recent Development
11.13 Osel
11.13.1 Osel Company Details
11.13.2 Osel Business Overview
11.13.3 Osel Human Microbiome Introduction
11.13.4 Osel Revenue in Human Microbiome Business (2016-2021)
11.13.5 Osel Recent Development
11.14 Symberix
11.14.1 Symberix Company Details
11.14.2 Symberix Business Overview
11.14.3 Symberix Human Microbiome Introduction
11.14.4 Symberix Revenue in Human Microbiome Business (2016-2021)
11.14.5 Symberix Recent Development
11.15 Miomics
11.15.1 Miomics Company Details
11.15.2 Miomics Business Overview
11.15.3 Miomics Human Microbiome Introduction
11.15.4 Miomics Revenue in Human Microbiome Business (2016-2021)
11.15.5 Miomics Recent Development
11.16 Symbiotix Biotherapies
11.16.1 Symbiotix Biotherapies Company Details
11.16.2 Symbiotix Biotherapies Business Overview
11.16.3 Symbiotix Biotherapies Human Microbiome Introduction
11.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2016-2021)
11.16.5 Symbiotix Biotherapies Recent Development
11.17 MicroBiome Therapeutics LLC
11.17.1 MicroBiome Therapeutics LLC Company Details
11.17.2 MicroBiome Therapeutics LLC Business Overview
11.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction
11.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2016-2021)
11.17.5 MicroBiome Therapeutics LLC Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Human Microbiome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gastrointestinal Tract Human Micobiome
Table 3. Key Players of Urogenital Tract Human Micobiome
Table 4. Key Players of Others
Table 5. Global Human Microbiome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Human Microbiome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Human Microbiome Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Human Microbiome Market Share by Regions (2016-2021)
Table 9. Global Human Microbiome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Human Microbiome Market Share by Regions (2022-2027)
Table 11. Human Microbiome Market Trends
Table 12. Human Microbiome Market Drivers
Table 13. Human Microbiome Market Challenges
Table 14. Human Microbiome Market Restraints
Table 15. Global Human Microbiome Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Human Microbiome Market Share by Players (2016-2021)
Table 17. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome as of 2020)
Table 18. Ranking of Global Top Human Microbiome Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Human Microbiome Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Human Microbiome Product Solution and Service
Table 22. Date of Enter into Human Microbiome Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Human Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Human Microbiome Revenue Market Share by Type (2016-2021)
Table 26. Global Human Microbiome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Human Microbiome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Human Microbiome Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Human Microbiome Revenue Market Share by Application (2016-2021)
Table 30. Global Human Microbiome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Human Microbiome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Human Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Human Microbiome Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Human Microbiome Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Human Microbiome Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Human Microbiome Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Human Microbiome Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Human Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Human Microbiome Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Human Microbiome Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Human Microbiome Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Human Microbiome Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Human Microbiome Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Human Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Human Microbiome Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Human Microbiome Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Human Microbiome Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Human Microbiome Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Human Microbiome Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Human Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Human Microbiome Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Human Microbiome Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Human Microbiome Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Human Microbiome Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Human Microbiome Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Human Microbiome Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Human Microbiome Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Human Microbiome Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Human Microbiome Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Human Microbiome Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Human Microbiome Market Size by Country (2022-2027) & (US$ Million)
Table 62. Vedanta Company Details
Table 63. Vedanta Business Overview
Table 64. Vedanta Human Microbiome Product
Table 65. Vedanta Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 66. Vedanta Recent Development
Table 67. Seres Therapeutics Company Details
Table 68. Seres Therapeutics Business Overview
Table 69. Seres Therapeutics Human Microbiome Product
Table 70. Seres Therapeutics Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 71. Seres Therapeutics Recent Development
Table 72. Second Genome Company Details
Table 73. Second Genome Business Overview
Table 74. Second Genome Human Microbiome Product
Table 75. Second Genome Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 76. Second Genome Recent Development
Table 77. Rebiotix Company Details
Table 78. Rebiotix Business Overview
Table 79. Rebiotix Human Microbiome Product
Table 80. Rebiotix Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 81. Rebiotix Recent Development
Table 82. ActoGeniX Company Details
Table 83. ActoGeniX Business Overview
Table 84. ActoGeniX Human Microbiome Product
Table 85. ActoGeniX Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 86. ActoGeniX Recent Development
Table 87. Enterome BioScience Company Details
Table 88. Enterome BioScience Business Overview
Table 89. Enterome BioScience Human Microbiome Product
Table 90. Enterome BioScience Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 91. Enterome BioScience Recent Development
Table 92. AvidBiotics Company Details
Table 93. AvidBiotics Business Overview
Table 94. AvidBiotics Human Microbiome Product
Table 95. AvidBiotics Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 96. AvidBiotics Recent Development
Table 97. 4D Pharma Research Ltd Company Details
Table 98. 4D Pharma Research Ltd Business Overview
Table 99. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 100. 4D Pharma Research Ltd Recent Development
Table 101. Enterologics Company Details
Table 102. Enterologics Business Overview
Table 103. Enterologics Human Microbiome Product
Table 104. Enterologics Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 105. Enterologics Recent Development
Table 106. Metabogen Company Details
Table 107. Metabogen Business Overview
Table 108. Metabogen Human Microbiome Product
Table 109. Metabogen Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 110. Metabogen Recent Development
Table 111. Metabiomics Company Details
Table 112. Metabiomics Business Overview
Table 113. Metabiomics Human Microbiome Product
Table 114. Metabiomics Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 115. Metabiomics Recent Development
Table 116. Ritter Pharmaceuticals Company Details
Table 117. Ritter Pharmaceuticals Business Overview
Table 118. Ritter Pharmaceuticals Human Microbiome Product
Table 119. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 120. Ritter Pharmaceuticals Recent Development
Table 121. Osel Company Details
Table 122. Osel Business Overview
Table 123. Osel Human Microbiome Product
Table 124. Osel Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 125. Osel Recent Development
Table 126. Symberix Company Details
Table 127. Symberix Business Overview
Table 128. Symberix Human Microbiome Product
Table 129. Symberix Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 130. Symberix Recent Development
Table 131. Miomics Company Details
Table 132. Miomics Business Overview
Table 133. Miomics Human Microbiome Product
Table 134. Miomics Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 135. Miomics Recent Development
Table 136. Symbiotix Biotherapies Company Details
Table 137. Symbiotix Biotherapies Business Overview
Table 138. Symbiotix Biotherapies Human Microbiome Product
Table 139. Symbiotix Biotherapies Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 140. Symbiotix Biotherapies Recent Development
Table 141. MicroBiome Therapeutics LLC Company Details
Table 142. MicroBiome Therapeutics LLC Business Overview
Table 143. MicroBiome Therapeutics LLC Human Microbiome Product
Table 144. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
Table 145. MicroBiome Therapeutics LLC Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Market Share by Type: 2020 VS 2027
Figure 2. Gastrointestinal Tract Human Micobiome Features
Figure 3. Urogenital Tract Human Micobiome Features
Figure 4. Others Features
Figure 5. Global Human Microbiome Market Share by Application: 2020 VS 2027
Figure 6. Treatment Case Studies
Figure 7. Diagnosis Case Studies
Figure 8. Human Microbiome Report Years Considered
Figure 9. Global Human Microbiome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Human Microbiome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Human Microbiome Market Share by Regions: 2020 VS 2027
Figure 12. Global Human Microbiome Market Share by Regions (2022-2027)
Figure 13. Global Human Microbiome Market Share by Players in 2020
Figure 14. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2020
Figure 16. Global Human Microbiome Revenue Market Share by Type (2016-2021)
Figure 17. Global Human Microbiome Revenue Market Share by Type (2022-2027)
Figure 18. North America Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Human Microbiome Market Share by Type (2016-2027)
Figure 20. North America Human Microbiome Market Share by Application (2016-2027)
Figure 21. North America Human Microbiome Market Share by Country (2016-2027)
Figure 22. United States Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Human Microbiome Market Share by Type (2016-2027)
Figure 26. Europe Human Microbiome Market Share by Application (2016-2027)
Figure 27. Europe Human Microbiome Market Share by Country (2016-2027)
Figure 28. Germany Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Human Microbiome Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Human Microbiome Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Human Microbiome Market Share by Region (2016-2027)
Figure 38. China Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Human Microbiome Market Share by Type (2016-2027)
Figure 46. Latin America Human Microbiome Market Share by Application (2016-2027)
Figure 47. Latin America Human Microbiome Market Share by Country (2016-2027)
Figure 48. Mexico Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Human Microbiome Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Human Microbiome Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Human Microbiome Market Share by Country (2016-2027)
Figure 54. Turkey Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Vedanta Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 58. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 59. Second Genome Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 60. Rebiotix Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 61. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 62. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 63. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 64. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 65. Enterologics Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 66. Metabogen Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 67. Metabiomics Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 68. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 69. Osel Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 70. Symberix Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 71. Miomics Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 72. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 73. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界のヒトマイクロバイオーム治療市場規模・現状・予測（2021年-2027年） Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Mic…- 世界のヒトマイクロバイオーム治療薬・診断市場規模・現状・予測（2021年-2027年） The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness. Rising cases of ch…
- 世界のヒトマイクロバイオームシーケンシング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Microbiome Sequencing Market The global Human Microbiome Sequencing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
- 世界のヒトマイクロバイオームシーケンシング技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Microbiome Sequencing Technology Market The global Human Microbiome Sequencing Technology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
- 世界のヒト免疫不全ウイルス（HIV）市場規模・現状・予測（2021年-2027年） HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person c…